You are using an older browser version. Please use a supported version for the best MSN experience.

NOVAVAX, INC.

NASDAQ: NVAX
57.59
-2.68
-4.45%
  • Key statistics
  • Growth
  • Profitability
  • Price ratios
Industry Biotechnology & Medical Research
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 1.15B

    • Net Income

    • -1.74B

    • Market Cap.

    • 4.50B

    • Enterprise Value

    • 3.58B

    • Net Profit Margin %

    • -152.12

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • -

    • Forward P/E

    • -

    • Price/Sales

    • -

    • Price/Book Value

    • -

    • Price/Cash flow

    • 17.74

      • EBITDA

      • -1.67B

      • Return on Capital %

      • -48.41

      • Return on Equity %

      • -238.60

      • Return on Assets %

      • -48.41

      • Book Value/Share

      • -

      • Shares Outstanding

      • -

      • Last Split Factor (Date)

      • 1:20 (5/10/2019)

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

        • Sales (Revenue)

          Q/Q (Last Year)

        • 57.41

        • 22.53

        • Net Income

          YTD/YTD (Last Year)

        • -316.91

        • 39.04

        • Net Income

          Q/Q (Last Year)

        • 191.33

        • -45.09

        • Sales (Revenue)

          5-Year Annual Average

        • 136.93

        • -

        • Net Income

          5-Year Annual Average

        • -

        • -

        • Dividends

          5-Year Annual Average

        • -

        • -

        • Profit Margins (%)

        • Company

        • Industry

        • Gross Margin

        • -

        • 66.16

        • Pre-Tax Margin

        • -149.57

        • -23.95

        • Net Profit Margin

        • -152.12

        • -18.83

        • Average Gross Margin

          5-Year Annual Average

        • -

        • 64.47

        • Average Pre-Tax Margin

          5-Year Annual Average

        • -154.40

        • -8.19

        • Average Net Profit Margin

          5-Year Annual Average

        • -156.11

        • -11.49

        • Price Ratios

        • Company

        • Industry

        • Current P/E Ratio

        • -

        • -

        • P/E Ratio 5-Year High

        • -

        • -

        • P/E Ratio 5-Year Low

        • -

        • -

        • Price/Sales Ratio

        • 4.11

        • 8.80

        • Price/Book Value

        • -

        • 5.75

        • Price/Cash Flow Ratio

        • 17.74

        • 20.93

        Current Historical
        • Financial health
        • Trading statistics
        • Management effectiveness
        Industry Biotechnology & Medical Research
        • Financial Ratios

        • Company

        • Industry

        • Debt/Equity Ratio

        • 0.00

        • 0.39

        • Current Ratio

        • 1.04

        • 3.58

        • Quick Ratio

        • -

        • 2.73

        • Leverage Ratio

        • 43.40

        • 1.92

        • Book Value/Share

        • 0.84

        • 1.66

        • Key Metrics

        • Company

          • Shares Short

            as of -

          • -

          • Short Ratio

            as of -

          • -

          • Short % of Float

            as of -

          • -

          • Shares Short

            prior month

          • -

          • Trailing Annual Dividend Yield

          • -

          • 5 Year Average Dividend Yield

          • 0.00

          • Key Metrics

          • Company

            • Payout Ratio

            • -

            • Dividend Date

            • -

            • Ex-Dividend Date

            • -

            • Last Split Factor

              new per old

            • 1:20

            • Last Split Date

            • 5/10/2019

            • Key Metrics

            • Company

            • Industry

            • Return on Equity %

              (5-Year Average)

            • -238.60

              (-)

            • -17.79

              (-6.36)

            • Return on Assets %

              (5-Year Average)

            • -48.41

              (-70.99)

            • -7.93

              (-3.17)

            • Return on Capital %

              (5-Year Average)

            • -133.52

              (-148.09)

            • -10.68

              (-3.79)

            • Income/Employee

            • -1.50M

            • 17.35k

            • Inventory Turnover

            • -

            • 2.60

            • Asset Turnover

            • 0.55

            • 0.36

            Current Historical
            AdChoices
            AdChoices
            AdChoices
            image beaconimage beaconimage beacon